The Minister noted that with the development and transfer of India's first indigenous CRISPR-based gene therapy, the nation ...

The gene editing solution for Sickle Cell Disease, a chronic, single-gene disorder that causes a debilitating systemic syndrome characterised by chronic anaemia ...

CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing ...

CSIR-IGIB and Serum Institute of India sign a tech transfer pact to develop an indigenous, affordable CRISPR-based gene-editing therapy for sickle cell disease ...

If the gene therapy treatment is proven to be effective in curing the sickle cell disease, it will initially be made available to people with severe sickle cell disease, maybe with organ damage.

In conjunction with Tract’s move to Connect Labs Charlotte, the company’s scientific co-founders, Frank McKeon, Ph.D., and Wa ...

Electrostatic forces play a pivotal part in calcium-induced phase separation of PDIA6 to form quality control granules, which suppress proinsulin amyloid-like aggregation and ensure correct proinsulin ...

Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral ...

Lyric Bio, Inc., (Lyric) a next-generation biomanufacturing startup developing human-tissue-based production systems for donor-derived therapeutics, has closed an oversubscribed $6.6 million seed ...

当代职场人“熬夜+酒局+高压”三件套已成常态，肝脏被迫“007”加班，脸色暗沉、代谢变慢、脂肪肝年轻化成为普遍痛点。市场上护肝产品从传统的“水飞蓟单方”到如今的“复合修护”层出不穷，消费者该如何选择？

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the ...